It’s no secret that the clinical research enterprise faces many struggles related to attracting and retaining qualified physicians to serve as principal investigators (PIs) for clinical trials. All too often, the first trial a PI completes is also their last one. However, when someone with a passion for research takes on the PI mantle as a true calling, it becomes part of their professional and personal identities.
One of the most common and important types of quality management measures in clinical research is the Corrective and Preventive Action (CAPA) plan. Learning the CAPA process will provide insight into how corrective and preventive actions are handled, along with creating an effective game plan for your use of CAPAs.
Decentralized clinical trials have emerged in popularity in the clinical research industry in recent years. Advantages and disadvantages to this clinical trial operations model are described here through the lens of quality management, participant outcomes, and data management.
While there is no “wrong” pathway to become a clinical research associate (CRA), the responses to a recent survey of current and former CRAs suggest an ideal pathway one might follow to optimize the ability for the potential candidate to receive as much experience as possible.
This article delves into the role of multi-omics in enhancing cancer clinical trials, highlighting its promise against the backdrop of frequent trial failures encountered in oncology research and limited success of precision medicine.